Programme Result - UK NEQAS

ACCREDITATION STATUS:

Pilot - Not Accredited

CLINICAL APPLICATION:

Thyroid papillary carcinoma, thyroid follicular carcinoma, poorly differentiated anaplastic thyroid carcinoma, thyroid medullary carcinoma, Phaeochromocytoma, adrenal cortical carcinoma, RET, BRAF, KRAS, NRAS, HRAS, TP53, KRAS, TERT promoter

PURPOSE OF PROGRAMME:

Testing for somatic small nucelotide variants in thryoid cancer.

MATERIAL PROVIDED: DNA in TE buffer

DISTRIBUTIONS PER YEAR: 1

SAMPLES PER DISTRIBUTION: 3

FREQUENCY OF DISTRIBUTION: 1

PROGRAMME OF ANALYSIS:

Small variant analysis only

DATA ANALYSIS:

Clinical Report

Details of the performance criteria for this programme can be obtained from UK NEQAS Genomics (GenQA) directly.

Email: info@genqa.org
Telephone: +44 (0) 131 2426898

Genomics (GenQA)

GenQA (Genomics Quality Assessment) provides external quality assessment (EQA) / proficiency testing (PT) to the genomics community worldwide. GenQA EQAs cover the entire clinical genomics service from patient counselling, sample preparation, testing processes, results interpretation and reporting. Laboratories and individual clinicians have access to more than 100 unique EQAs available for a range of rare and inherited disorders and acquired diseases. Please click here for an overview of GenQA For the most up-to-date scheme information (including any pilot schemes) please contact the centre directly.

Contact Details

Genomics (GenQA)

GenQA (Edinburgh)
Nine, Edinburgh Bioquarter
Little France Road
Edinburgh
EH16 4UX

Data Entry

Thyroid cancer (Pilot)

Summary

ACCREDITATION STATUS:

CLINICAL APPLICATION:

PURPOSE OF PROGRAMME:

Analysis

PROGRAMME OF ANALYSIS:

DATA ANALYSIS:

Performance

About the Centre

Genomics (GenQA)

Contact Details

Genomics (GenQA)